Insights from Meta-analysis Of Studies Using Machine Learning To Predict Mortality, ReadmissioCell-004: A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR (AAV1/SERCA2a) in Subjects with Heart Failure. University of Miamin, Or Other Outcomes Among Heart Failure Patients